DTPa webinar

Learning Objectives

• review the epidemiology, disease burden and Australian immunisation rates of DTPa in children under five years of age
• explain the importance of DTPa immunisation and the rationale behind the five dose NIP schedule (2, 4, 6, 18 and 48 months of age)
• summarise the key reasons behind the declining vaccination rate and detail practical strategies for HCPs and parents that lead to reversing the decline
• summarise available real-world experience on DTPa vaccines including global vaccination rates, strategies to address this, and a focus on safety, efficacy and effectiveness.

Discuss the need for ongoing evidence generation and post-marketing surveillance of DTPa immunisation, to support continued evaluation and confidence of DTPa immunisation.